What explains the diffusion of treatments for mental illness?

Am J Psychiatry. 2008 Nov;165(11):1385-92. doi: 10.1176/appi.ajp.2008.08030334.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / economics
  • Antipsychotic Agents / therapeutic use
  • Cost-Benefit Analysis / trends
  • Diffusion of Innovation*
  • Drug Costs / trends
  • Evidence-Based Medicine / economics
  • Forecasting
  • Health Policy / economics
  • Health Policy / trends
  • Humans
  • Insurance Coverage / economics
  • Marketing of Health Services / economics
  • Medicaid / economics
  • Mental Disorders / diagnosis
  • Mental Disorders / economics
  • Mental Disorders / psychology
  • Mental Disorders / therapy*
  • Prejudice
  • Quality Assurance, Health Care / economics
  • Research*
  • Schizophrenia / drug therapy
  • Schizophrenia / economics
  • United States

Substances

  • Antipsychotic Agents